Krótki terminŚredni terminDługi terminSygnały

Nurix Therapeutics Inc [NRIX]

Giełda: NASDAQ
Sektor: Healthcare
Branża: Biotechnology
Ostatnia aktualizacja 15 Jun 2026 @ 16:00 (Exchange is closed)
Ostatnia: $17.04 0.53%
1.22 (↑)
GaG Algo Score™
v1.0
Krótki
1.22 (↑)
Średni
3.09 (↑)
Długi
2.92 (↑)
KUP
72.00%
zwrot 42.39%
SPRZEDAJ
30.61%
zwrot 47.63%

Statystyki

Dzisiejszy wolumen 2.68M
Średni wolumen 1.72M
Kapitalizacja 1.48B
EPS $-0.790 (Q1 | 2026-04-08)
Następna data wyników ($-0.730) 2026-07-09
P/E -5.38 (Sektor) 26.21 (Branża) 17.28
ATR14 $1.135 (6.66%)
Możliwy ruch dzienny $16.47 - $17.61 (6.89%)

Poziomy wsparcia i oporu

Linia

Dane pivot

Statystyki pivot
Metryka Średnia Mediana Odch. std.
Zysk % 32.51% 29.51% 25.43%
Strata % -17.65% -15.47% 11.35%
Czas trwania 20.3d 16d 15.1d
Łącznie znalezionych pivotów 46
Odcinki zysk/strata 45 (22 Zysk / 23 Strata)
Ostatni pivot Top @ $17.76 dnia 2026-05-29
Zmiana od ostatniego pivotu $-0.72 (-4.05%)
Prognoza następnego pivotu Ostatnia: $17.04
Przewidywany następny typ Bottom
Prognozowana cena (średnia) $14.63
Prognozowana cena (mediana) $15.01
Prognozowany zakres ceny (~68%) $12.61 - $16.64
Zmiana do średniego celu $-2.41 (-14.17%)
Prognozowana data (średnia) 2026-06-18
Prognozowany zakres dat (~68%) 2026-06-03 - 2026-07-03
Podstawa Based on 23 historical losses (Avg: -17.65%, Median: -15.47%, StdDev of Abs: 11.35%) and duration (Avg: 20.3 days, StdDev: 15.1 days)
Uwaga Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Nurix Therapeutics Inc gained modestly, up 0.53%.

Nurix Therapeutics Inc (NRIX) stock price moved up modestly on Monday after the stock rose $0.0900 (0.53%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 3.07% rise. With 2.68M shares traded, volume yesterday reached $45.70M. This was 118 926 shares more than the prior day. Compared to the 10-day average of 4.33M shares, volume was the same as the average.

Nurix Therapeutics Inc signals

There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (23.3%), medium- (23.3%), and long-term (23.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Nurix Therapeutics Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $17.50. approximately $0.460 (2.70%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -

Nurix Therapeutics Inc Evaluation

  • Krótki wynik: 1.22
  • Średni wynik: 3.09
  • Długi wynik: 2.92